Literature DB >> 30659819

Hierarchical Condition Categories for Pulmonary Diseases: Population Health Management and Policy Opportunities.

Gary E Weissman1.   

Abstract

Hierarchical condition categories (HCCs) are groups of diagnostic codes that are used to adjust federal payments to insurers and health systems based on differences in expected spending. Risk models built on HCCs improve on previous adjustment strategies that used demographic characteristics but did not include clinical diagnoses. Thus, accurate coding by clinicians of inpatient and outpatient encounters ensures capitated payments and reimbursements that are commensurate with predicted expenditures. Pulmonary diseases and various forms of critical illness play a significant role in this risk adjustment process both through their associated HCC codes and through interactions with other risk categories representing cardiac and psychiatric diseases. Ongoing uncertainty in federal health policy ensures a changing role for HCCs and risk-adjusted reimbursements across a variety of payment models and federal programs.
Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  critical care; health administration; health-care utilization; politics; pulmonary

Mesh:

Year:  2019        PMID: 30659819      PMCID: PMC6514430          DOI: 10.1016/j.chest.2018.12.013

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Transitional care management reimbursement to reduce COPD readmission.

Authors:  Shreya Kangovi; David Grande
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

2.  Integrating Medical and Nonmedical Services - The Promise and Pitfalls of the CHRONIC Care Act.

Authors:  Amber Willink; Eva H DuGoff
Journal:  N Engl J Med       Date:  2018-06-07       Impact factor: 91.245

3.  Sample Selection for Medicare Risk Adjustment Due to Systematically Missing Data.

Authors:  Savannah L Bergquist; Thomas G McGuire; Timothy J Layton; Sherri Rose
Journal:  Health Serv Res       Date:  2018-09-11       Impact factor: 3.402

4.  Frailty and Clinical Outcomes in Chronic Obstructive Pulmonary Disease.

Authors:  Cassie C Kennedy; Paul J Novotny; Nathan K LeBrasseur; Robert A Wise; Frank C Sciurba; Roberto P Benzo
Journal:  Ann Am Thorac Soc       Date:  2019-02

5.  The Evolution of Private Plans in Medicare.

Authors:  Yash M Patel; Stuart Guterman
Journal:  Issue Brief (Commonw Fund)       Date:  2017-12-01

6.  Disease Management plus Recommended Care versus Recommended Care Alone for Ambulatory Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Ofra Kalter-Leibovici; Michal Benderly; Laurence S Freedman; Galit Kaufman; Tchiya Molcho Falkenberg Luft; Havi Murad; Liraz Olmer; Meri Gluch; David Segev; Avi Gilad; Said Elkrinawi; Tali Cukierman-Yaffe; Baruch Chen; Orit Jacobson; Calanit Key; Mordechai Shani; Gershon Fink
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

7.  Linking Neighborhood Context and Health in Community-Dwelling Older Adults in the Medicare Advantage Program.

Authors:  Daniel Jung; Amy Kind; Stephanie Robert; William Buckingham; Eva DuGoff
Journal:  J Am Geriatr Soc       Date:  2018-04-12       Impact factor: 5.562

8.  Why Effective Interventions Do Not Work for All Patients: Exploring Variation in Response to a Chronic Disease Management Intervention.

Authors:  Merritt Edlind; Nandita Mitra; David Grande; Frances K Barg; Tamala Carter; Lindsey Turr; Karen Glanz; Judith A Long; Shreya Kangovi
Journal:  Med Care       Date:  2018-08       Impact factor: 2.983

9.  Multimorbidity, frailty and chronic obstructive pulmonary disease: Are the challenges for pulmonary rehabilitation in the name?

Authors:  Anne E Holland; Samantha L Harrison; Dina Brooks
Journal:  Chron Respir Dis       Date:  2016-10-26       Impact factor: 2.444

10.  Risk adjustment of Medicare capitation payments using the CMS-HCC model.

Authors:  Gregory C Pope; John Kautter; Randall P Ellis; Arlene S Ash; John Z Ayanian; Lisa I Lezzoni; Melvin J Ingber; Jesse M Levy; John Robst
Journal:  Health Care Financ Rev       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.